Other news to note
Tuesday, May 6, 2014
Kinex Pharmaceuticals Inc., of Buffalo, N.Y., said it has filed an investigational new drug application (IND) for Oratecan, an oral form of the chemotherapy agent irinotecan with enhanced oral absorption.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.